Patent US5154391A successfully refreshed from Google Patents.
EP0302793A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
Assignee: Sanofi Belgium
•
Filing: 1988-08-03
•
Granted: —
•
Expires: 2008-08-03
Abstract
Abstract The present invention relates to aminoalkoxyphenyl derivatives of formula : in which : B represents a -S-, -SO- of SO₂- group, and C y is an organic cyclic group. These compounds are calcium inhibitors and are useful for the treatment of pathological syndroms of the cardiovascular system.
Inventors
- 👤 Jean Gubin
- 👤 Pierre Chatelain
- 👤 Henri Inion
- 👤 Jean Lucchetti
- 👤 Jean-Marie Mahaux
- 👤 Jean-Noel Vallat
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-05 11:37
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/62; C07D213/70; A; A61; A61P; A61P25/00; A61P25/02; A61P3/00; A61P35/00; A61P43/00; A61P9/00; A61P9/06; A61P9/08; A61P9/10; A61P9/12; C07C; C07C309/00; C07C317/00; C07C317/16; C07C317/22; C07D207/00; C07D207/02; C07D207/18; C07D207/22; C07D207/24; C07D209/00; C07D209/02; C07D209/04; C07D209/30; C07D213/71; C07D215/00; C07D215/02; C07D215/16; C07D215/36; C07D231/00; C07D231/02; C07D231/10; C07D231/14; C07D231/18; C07D233/00; C07D233/54; C07D233/66; C07D233/84; C07D235/00; C07D235/02; C07D235/04; C07D235/22; C07D235/24; C07D235/28; C07D237/00; C07D237/26; C07D237/28; C07D239/00; C07D239/02; C07D239/24; C07D239/28; C07D239/32; C07D239/38; C07D261/00; C07D261/02; C07D261/06; C07D261/10; C07D277/00; C07D277/02; C07D277/20; C07D277/32; C07D277/36; C07D307/00; C07D307/02; C07D307/26; C07D307/30; C07D307/34; C07D307/56; C07D307/64; C07D307/77; C07D307/78; C07D307/82; C07D317/00; C07D317/08; C07D317/44; C07D317/46; C07D317/48; C07D317/50; C07D317/58; C07D333/00; C07D333/50; C07D333/52; C07D333/62; C07D471/00; C07D471/02; C07D471/04; C07D487/00; C07D487/02; C07D487/04; C07D495/00; C07D495/02; C07D495/04; C07C2601/00; C07C2601/12; C07C2601/16; C07C2602/00; C07C2602/02; C07C2602/04; C07C2602/08
Claims Analysis
Total Claims: 39
Claim 1
Independent Claim
497 words
An aminoalkoxyphenyl derivative of formula : in which : B represents a -S-, -SO- or -SO₂- group, R₁ and R₂, which are identical or different, each denote hydrogen, a methyl or ethyl radical or a halogen, A denotes a straight- or branched-alkylene radical having from 2 to 5 carbon atoms or a 2-hydroxypropylene radical in which the hydroxy is optionally substituted by a lower alkyl radical in C₁-C₄, R₃ denotes hydrogen or an alkyl radical in C₁-C₈, R₄ denotes a pyridyl, phenyl, 2,3-methylenedioxyphenyl or 3,4-methylenedioxyphenyl radical or a phenyl group substituted with one or more substituents, which may be identical or different, selected from halogen atoms, lower alkyl groups in C₁-C₄ or lower alkoxy groups in C₁-C₄, Alk denotes a single bond or a linear- or branched-alkylene radical having from 1 to 5 carbon atoms, Cy represents a group of formula : R represents hydrogen, an alkyl radical in C₁-C₈, a cycloalkyl radical in C₃-C₆, a benzyl radical or a phenyl radical optionally substituted with one or more substituents, which may be identical or different, selected from halogen atoms and from lower alkyl in C₁-C₄, lower alkoxy in C₁-C₄ or nitro groups, R₅ and R₆ are taken together with the carbon atom to which they are attached to form : - an optionally aromatic mono- or di-cyclic carboxylic group having from 5 to 10 carbon atoms and optionally substituted by a R group in the α-position with respect to the methyne group, - an optionally aromatic 5-membered heterocyclic group, the heteroatoms or heterogroups being selected from the groups O, S, N, -Ń-R₁₁ in which R₁₁ denotes hydrogen or a lower alkyl in C₁-C 4′ phenyl, benzyl or halogenobenzyl radical; O and N; O and -Ń-R₁₁; S and N; S and -Ń-R₁₁; N and N; N and -Ń-R₁₁, the heterocyclic group being optionally substituted by a R group in the α-position with respect to the methyne group and optionally substituted by one or two groups selected from lower alkyl in C₁-C₄ and phenyl groups, - an optionally aromatic 6- to 10-membered mono- or di-cyclic heterocyclic group, the heteroatoms or heterogroups being selected from the groups O, S, N, -Ń-R₁₁; O and N; O and -Ń-R₁₁; S and N; S and -Ń-R₁₁; N and N; N and -Ń-R₁₁, the heterocyclic group being optionally substituted by a R group in the α-position with respect to the methyne group, R₇ and R₈, which are the same or different, each represent hydrogen, a lower alkyl radical in C₁-C₄ or a phenyl radical or when they are taken together with the carbon atoms to which they are attached, represent an optionally aromatic 6-membered carbocyclic ring, R₉ represents oxygen or sulphur, R₁₀ represents oxygen, sulphur or a group -Ń-R₁₁ R₁₂ and R₁₃, which are identical or different, each represent hydrogen, a lower alkyl radical in C₁-C₄ or a benzoyl radical, with the proviso that Cy does not represent a 1-indolizinyl group, as well as the N-oxide derivative thereof and a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim
497 words
An aminoalkoxyphenyl derivative of formula : in which : B represents a -S-, -SO- or -SO₂- group, R₁ and R₂, which are identical or different, each denote hydrogen, a methyl or ethyl radical or a halogen, A denotes a straight- or branched-alkylene radical having from 2 to 5 carbon atoms or a 2-hydroxypropylene radical in which the hydroxy is optionally substituted by a lower alkyl radical in C₁-C₄, R₃ denotes hydrogen or an alkyl radical in C₁-C₈, R₄ denotes a pyridyl, phenyl, 2,3-methylenedioxyphenyl or 3,4-methylenedioxyphenyl radical or a phenyl group substituted with one or more substituents, which may be identical or different, selected from halogen atoms, lower alkyl groups in C₁-C₄ or lower alkoxy groups in C₁-C₄, Alk denotes a single bond or a linear- or branched-alkylene radical having from 1 to 5 carbon atoms, Cy represents a group of formula : R represents hydrogen, an alkyl radical in C₁-C₈, a cycloalkyl radical in C₃-C₆, a benzyl radical or a phenyl radical optionally substituted with one or more substituents, which may be identical or different, selected from halogen atoms and from lower alkyl in C₁-C₄, lower alkoxy in C₁-C₄ or nitro groups, R₅ and R₆ are taken together with the carbon atom to which they are attached to form : - an optionally aromatic mono- or di-cyclic carboxylic group having from 5 to 10 carbon atoms and optionally substituted by a R group in the α-position with respect to the methyne group, - an optionally aromatic 5-membered heterocyclic group, the heteroatoms or heterogroups being selected from the groups O, S, N, -Ń-R₁₁ in which R₁₁ denotes hydrogen or a lower alkyl in C₁-C 4′ phenyl, benzyl or halogenobenzyl radical; O and N; O and -Ń-R₁₁; S and N; S and -Ń-R₁₁; N and N; N and -Ń-R₁₁, the heterocyclic group being optionally substituted by a R group in the α-position with respect to the methyne group and optionally substituted by one or two groups selected from lower alkyl in C₁-C₄ and phenyl groups, - an optionally aromatic 6- to 10-membered mono- or di-cyclic heterocyclic group, the heteroatoms or heterogroups being selected from the groups O, S, N, -Ń-R₁₁; O and N; O and -Ń-R₁₁; S and N; S and -Ń-R₁₁; N and N; N and -Ń-R₁₁, the heterocyclic group being optionally substituted by a R group in the α-position with respect to the methyne group, R₇ and R₈, which are the same or different, each represent hydrogen, a lower alkyl radical in C₁-C₄ or a phenyl radical or when they are taken together with the carbon atoms to which they are attached, represent an optionally aromatic 6-membered carbocyclic ring, R₉ represents oxygen or sulphur, R₁₀ represents oxygen, sulphur or a group -Ń-R₁₁ R₁₂ and R₁₃, which are identical or different, each represent hydrogen, a lower alkyl radical in C₁-C₄ or a benzoyl radical, with the proviso that Cy does not represent a 1-indolizinyl group, as well as the N-oxide derivative thereof and a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
53 words
An aminoalkoxyphenyl derivative according to Claim 1 in which Cy represents a phenyl, cyclohexenyl, indenyl, naphthyl, dihydronaphthyl, pyridyl, dihydropyridyl, furyl, dihydrofuryl, thienyl, dihydrothienyl, pyrrolyl, dihydropyrrolyl, pyrazolyl, imidazolyl, pyrimidyl, pyrazinyl, pyridazinyl, oxazolyl, isoxazolyl, thiazolyl, benzofuryl, benzothienyl, indolyl, benzimidazolyl, benzoxazolyl, quinolinyl, benzisoxazolyl, cinnolinyl, quinoxalinyl, quinazolinyl, indolizin-3-yl, thienopyridyl, tetrahydrothienopyridyl, pyrrolopyridyl, pyrazolopyridyl, pyrrolopyridazinyl, imidazopyridyl, dihydrofuranonyl, imidazolinonyl, chromonyl.
Claim 4
Dependent Claim
13 words
An aminoalkoxyphenyl derivative according to Claim 1 in which B represents a -SO₂-group.
Claim 5
Dependent Claim
22 words
An aminoalkoxyphenyl derivative according to Claim 1 in which Cy represents an indolizin-3-yl, benzofuryl, benzothienyl, indolyl, quinolinyl, pyrrolo[1,2-b]pyridazinyl, pyrazolo[1,5-a]pyridyl or imidazo[1,2-a]pyridyl group.
Claim 6
Dependent Claim
16 words
An aminoalkoxyphenyl derivative according to Claim 1 in which R represents an isopropyl or cyclopropyl group.
Claim 7
Dependent Claim
14 words
An aminoalkoxyphenyl derivative according to Claim 3 wherein the group represents a [N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy group.
Claim 8
Dependent Claim
17 words
An aminoalkoxyphenyl derivative according to Claim 1 wherein the pharmaceutically acceptable salt is the oxalate or hydrochloride.
Claim 9
Dependent Claim
156 words
Process for preparing an aminoalkoxyphenyl derivative according to claim 1 in which A represents an alkylene radical and B represents a -S- or -SO₂- group, whereby a 4-alkoxyphenyl derivative of general formula : in which B′ represents a -S- or -SO₂- group, Cy, B′, R₁ and R₂ have the same meaning as in Claim 1, A represents an alkylene radical as in Claim 1 and X represents a halogen atom, an alkylsulphonyloxy group having from 1 to 4 carbon atoms or an arylsulphonyloxy group having from 6 to 10 carbon atoms is condensed in the presence of an acid acceptor and in a polar or non-polar solvent, with an amine of general formula : in which R₃, Alk and R₄ have the same meaning as above, to form the desired aminoalkoxyphenyl derivative in free base form which can, if desired, be reacted with a suitable organic or inorganic acid to form a pharmaceutically acceptable salt thereof.
Claim 10
Dependent Claim
172 words
Process for preparing an aminoalkoxyphenyl derivative according to Claim 1 in which A represents an alkylene radical and B represents a -S- or -SO₂- group, whereby a 4-hydroxyphenyl derivative of general formula : in which B′ represents a -S- or -SO₂- group and Cy, R₁ and R₂ have the ame meaning as in Claim 1, is reacted, in the presence of a basic agent, with a compound of general formula : in which X represents a halogen atom, an alkylsulphonyloxy group having from 1 to 4 carbon atoms or an arylsulphonyloxy group having from 6 to 10 carbon atoms, A represents an alkylene radical as in Claim 1 and R₃, R₄ and Alk have the same meaning as in Claim 1, the reaction taking place at a temperature between room-temperature and the refluxing temperature of the medium and in a polar solvent, to obtain the desired aminoalkoxyphenyl derivative in free base form which can, if desired, be reacted with a suitable organic or inorganic acid to form a pharmaceutically acceptable salt thereof.
Claim 11
Dependent Claim
206 words
Process for preparing an aminoalkoxyophenyl derivative according to Claim 1 in which B represents a -S- or -SO₂- group and A represents an optionally substituted 2-hydroxy-propylene chain, whereby an oxiranylmethoxy derivative of general formula : in which Cy, R₁ and R₂ have the same meaning as in Claim 1 and B′ represents a -S- or -SO₂- group is treated under reflux, with an amine of general formula : in which R₃, Alk and R₄ have the same meaning as in Claim 1, this being performed in a polar solvent or in an excess of the said amine : - to give the desired aminoalkoxyphenyl derivative in the form of the free base in which A represents a 2-hydroxypropylene chain, - to give an aminoalkoxyphenyl derivative which can be reacted with an alkyl halide having from 1 to 4 carbon atoms in the presence of a strong base to provide the desired aminoalkoxyphenyl derivative in the form of the free base in which A represents a 2-hydroxypropylene chain in which the hydroxy is substituted by an alkyl having from 1 to 4 carbon atoms, the aminoalkoxyphenyl derivative so obtained being reacted, if desired, with a suitable organic or inorganic acid to form a pharmaceutically acceptable salt thereof.
Claim 12
Dependent Claim
92 words
Process for preparing an aminoalkoxyphenyl derivative according to Claim 1 in which B represents a -SO- group, whereby a sulphide of general formula : in which Cy, R₁, R₂, R₃, R₄, A and Alk have the same meaning as in Claim 1, is treated with an oxidizing agent, this sulphide being in the form of the free base or a salt thereof, to form the desired aminoalkoxyphenyl derivative in free base form which can, if desired, be reacted with a suitable organic or inorganic acid to form a pharmaceutically acceptable salt thereof.
Claim 13
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]indolizine and its N-oxide and pharmaceutially acceptable salts.
Claim 14
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]indolizine and its N-oxide and pharmaceutially acceptable salts.
Claim 15
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]benzofuran and its N-oxide and pharmaceutically acceptable salts.
Claim 16
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]benzofuran and its N-oxide and pharmaceutically acceptable salts.
Claim 17
Dependent Claim
8 words
2-n-Propyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]benzofuran and its N-oxide and pharmaceutically acceptable salts.
Claim 18
Dependent Claim
8 words
2-n-Propyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]benzofuran and its N-oxide and pharmaceutically acceptable salts.
Claim 19
Dependent Claim
8 words
2-n-Propyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]benzothiophene and its N-oxide and pharmaceutically acceptable salts.
Claim 20
Dependent Claim
8 words
2-n-Propyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]benzothiophene and its N-oxide and pharmaceutically acceptable salts.
Claim 21
Dependent Claim
8 words
2-n-Butyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]benzofuran and its N-oxide and pharmaceutically acceptable salts.
Claim 22
Dependent Claim
8 words
2-n-Butyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]benzofuran and its N-oxide and pharmaceutically acceptable salts.
Claim 23
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]quinoline and its N-oxide and pharmaceutically acceptable salts.
Claim 24
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]quinoline and its N-oxide and pharmaceutically acceptable salts.
Claim 25
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]pyrazolo[1,5-a]pyridine and its N-oxide and pharmaceutically acceptable salts.
Claim 26
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]pyrazolo[1,5-a]pyridine and its N-oxide and pharmaceutically acceptable salts.
Claim 27
Dependent Claim
8 words
5-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]-6-isopropyl-pyrrolo[1,2-b]pyridazine and its N-oxide and pharmaceutically acceptable salts.
Claim 28
Dependent Claim
8 words
5-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]-6-isopropyl-pyrrolo[1,2-b]pyridazine and its N-oxide and pharmaceutically acceptable salts.
Claim 29
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]-4,5-dihydrofuran and its N-oxide and pharmaceutically acceptable salts.
Claim 30
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]-4,5-dihydrofuran and its N-oxide and pharmaceutically acceptable salts.
Claim 31
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]furan and its N-oxide and pharmaceutically acceptable salts.
Claim 32
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]furan and its N-oxide and pharmaceutically acceptable salts.
Claim 33
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]indole and its N-oxide and pharmaceutically acceptable salts.
Claim 34
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]indole and its N-oxide and pharmaceutically acceptable salts.
Claim 35
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]-1-methyl-indole and its N-oxide and pharmaceutically acceptable salts.
Claim 36
Dependent Claim
8 words
2-Isopropyl-3-[4-{3-[N-methyl-N-(3,4-dimethoxy-β-phenethyl)amino]propyloxy}benzenesulphonyl]-1-methyl-indole and its N-oxide and pharmaceutically acceptable salts.
Claim 37
Dependent Claim
15 words
An aminoalkoxyphenyl derivative according to Claim 1 in which R₁ and R₂ each are hydrogen.
Claim 38
Dependent Claim
24 words
Process for the preparation of a pharmaceutical composition, comprising putting at least one aminoalkoxyphenyl derivative according to claim 1 in a pharmaceutically acceptable form.
Claim 39
Dependent Claim
24 words
Process for the preparation of a veterinary composition, comprising putting at least one aminoalkxyphenyl derivative according to claim 1 in a pharmaceutically acceptable form.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.